View in EDS HTML Full Text PDF Full Text

Developing CAR-T/NK cells that target EphA2 for non-small cell lung cancer treatment.

Saved in:
Bibliographic Details
Title: Developing CAR-T/NK cells that target EphA2 for non-small cell lung cancer treatment.
Authors: Kim SM; Center for Gene & Cell Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea., Lee SY; Center for Gene & Cell Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea., Kim SI; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungbuk, Republic of Korea.; College of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju-si, Chungbuk, Republic of Korea., Bae JY; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungbuk, Republic of Korea.; College of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju-si, Chungbuk, Republic of Korea., Hong JT; College of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju-si, Chungbuk, Republic of Korea., Jo S; Center for Gene & Cell Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.; Department of Functional Genomics, KRIBB School of Bioscience, Korea University of Science and Technology (UST), Daejeon, Republic of Korea., Kim JH; Center for Gene & Cell Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.; Department of Functional Genomics, KRIBB School of Bioscience, Korea University of Science and Technology (UST), Daejeon, Republic of Korea., Chung HY; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungbuk, Republic of Korea., Kim TD; Center for Gene & Cell Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.; Department of Functional Genomics, KRIBB School of Bioscience, Korea University of Science and Technology (UST), Daejeon, Republic of Korea.
Source: Frontiers in immunology [Front Immunol] 2025 Mar 13; Vol. 16, pp. 1448438. Date of Electronic Publication: 2025 Mar 13 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40181964
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Developing CAR-T/NK cells that target EphA2 for non-small cell lung cancer treatment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kim+SM%22">Kim SM</searchLink>; Center for Gene & Cell Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+SY%22">Lee SY</searchLink>; Center for Gene & Cell Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+SI%22">Kim SI</searchLink>; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungbuk, Republic of Korea.; College of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju-si, Chungbuk, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Bae+JY%22">Bae JY</searchLink>; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungbuk, Republic of Korea.; College of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju-si, Chungbuk, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Hong+JT%22">Hong JT</searchLink>; College of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju-si, Chungbuk, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jo+S%22">Jo S</searchLink>; Center for Gene & Cell Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.; Department of Functional Genomics, KRIBB School of Bioscience, Korea University of Science and Technology (UST), Daejeon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+JH%22">Kim JH</searchLink>; Center for Gene & Cell Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.; Department of Functional Genomics, KRIBB School of Bioscience, Korea University of Science and Technology (UST), Daejeon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Chung+HY%22">Chung HY</searchLink>; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungbuk, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+TD%22">Kim TD</searchLink>; Center for Gene & Cell Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.; Department of Functional Genomics, KRIBB School of Bioscience, Korea University of Science and Technology (UST), Daejeon, Republic of Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Mar 13; Vol. 16, pp. 1448438. <i>Date of Electronic Publication: </i>2025 Mar 13 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40181964
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2025.1448438
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1448438
    Titles:
      – TitleFull: Developing CAR-T/NK cells that target EphA2 for non-small cell lung cancer treatment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kim SM
      – PersonEntity:
          Name:
            NameFull: Lee SY
      – PersonEntity:
          Name:
            NameFull: Kim SI
      – PersonEntity:
          Name:
            NameFull: Bae JY
      – PersonEntity:
          Name:
            NameFull: Hong JT
      – PersonEntity:
          Name:
            NameFull: Jo S
      – PersonEntity:
          Name:
            NameFull: Kim JH
      – PersonEntity:
          Name:
            NameFull: Chung HY
      – PersonEntity:
          Name:
            NameFull: Kim TD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 03
              Text: 2025 Mar 13
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1